|
OMIM |
Link |
Information gain |
01 |
|
GPS
|
[NCBI]
|
0.00501984
|
|
|
hemophilia a
|
[NCBI]
|
0.00482602
|
|
|
scott syndrome
|
[NCBI]
|
0.0012344
|
|
|
von willebrand disease
|
[NCBI]
|
0.00122809
|
|
|
von willebrand disease, recessive form
|
[NCBI]
|
0.00122166
|
|
|
F5F8D
|
[NCBI]
|
0.000603325
|
|
|
giant platelet syndrome
|
[NCBI]
|
0.000484233
|
|
|
factor viii deficiency
|
[NCBI]
|
0.000455824
|
|
|
pseudo-von willebrand disease
|
[NCBI]
|
0.00033536
|
|
|
von willebrand disease, x-linked form
|
[NCBI]
|
0.000303599
|
|
|
LRP1
|
[NCBI]
|
0.000236613
|
|
|
HHT
|
[NCBI]
|
0.000221451
|
|
|
RA
|
[NCBI]
|
0.000221007
|
|
|
hemangioma-thrombocytopenia syndrome
|
[NCBI]
|
0.000176731
|
|
|
F8FD9
|
[NCBI]
|
0.000151659
|
|
|
vascular malformation, primary intraosseous
|
[NCBI]
|
0.000151659
|
|
|
factor vii and factor viii, combined deficiency of
|
[NCBI]
|
0.000151659
|
|
|
fibrinolytic defect
|
[NCBI]
|
0.000151659
|
|
|
factor ix and factor xi, combined deficiency of
|
[NCBI]
|
0.000151659
|
|
|
hemophilia a with vascular abnormality
|
[NCBI]
|
0.000151659
|
|
|
globulin anomaly involving beta (2a)-globulin
|
[NCBI]
|
0.000151659
|
|
|
diabetes insipidus, nephrogenic, x-linked
|
[NCBI]
|
0.000143614
|
|
|
HPS
|
[NCBI]
|
0.000134212
|
|
|
EDMD
|
[NCBI]
|
0.000133978
|
|
|
factors viii, ix and xi, combined deficiency of
|
[NCBI]
|
0.000120097
|
|
|
glanzmann thrombasthenia, autosomal dominant
|
[NCBI]
|
0.000120097
|
|
|
IP
|
[NCBI]
|
0.00011186
|
|
|
F3
|
[NCBI]
|
0.000107771
|
|
|
HEMB
|
[NCBI]
|
0.000105373
|
|
|
TFPI
|
[NCBI]
|
0.00010375
|
|
|
F8A
|
[NCBI]
|
9.3388e-05
|
|
|
VEGF
|
[NCBI]
|
8.86411e-05
|
|
|
anemia, dyserythropoietic congenital, type i
|
[NCBI]
|
8.64137e-05
|
|
|
CF
|
[NCBI]
|
8.30927e-05
|
|
|
afibrinogenemia, congenital
|
[NCBI]
|
7.35426e-05
|
|
|
vitamin k-dependent clotting factors, combined deficiency of, 1
|
[NCBI]
|
7.16706e-05
|
|
|
factor viii-associated gene 2
|
[NCBI]
|
7.02697e-05
|
|
|
diabetes insipidus, nephrogenic, autosomal
|
[NCBI]
|
6.99451e-05
|
|
|
MFGE8
|
[NCBI]
|
6.93582e-05
|
|
|
factor xii deficiency
|
[NCBI]
|
6.29085e-05
|
|
|
LRE1
|
[NCBI]
|
5.78859e-05
|
|
|
TTP
|
[NCBI]
|
5.76017e-05
|
|
|
ED1
|
[NCBI]
|
5.33512e-05
|
|
|
MPP1
|
[NCBI]
|
4.78816e-05
|
|
|
HAE
|
[NCBI]
|
3.97287e-05
|
|
|
factor v deficiency
|
[NCBI]
|
3.71098e-05
|
|
|
PF4
|
[NCBI]
|
3.63434e-05
|
|
|
FGF1
|
[NCBI]
|
3.40034e-05
|
|
|
EMD
|
[NCBI]
|
3.31237e-05
|
|
|
fragile x mental retardation syndrome
|
[NCBI]
|
2.88302e-05
|
|
|
PTH
|
[NCBI]
|
2.8438e-05
|
|
|
TNF
|
[NCBI]
|
2.77477e-05
|
|
|
BRCC3
|
[NCBI]
|
2.77119e-05
|
|
|
ALPS
|
[NCBI]
|
2.69327e-05
|
|
|
fabry disease
|
[NCBI]
|
2.63434e-05
|
|
|
DDR2
|
[NCBI]
|
2.49175e-05
|
|
|
GFAP
|
[NCBI]
|
2.4017e-05
|
|
|
F13A1
|
[NCBI]
|
2.37523e-05
|
|
|
MUC1
|
[NCBI]
|
2.3058e-05
|
|
|
B4GALNT2
|
[NCBI]
|
2.176e-05
|
|
|
VBP1
|
[NCBI]
|
2.06893e-05
|
|
|
ACHE
|
[NCBI]
|
1.87467e-05
|
|
|
EGF
|
[NCBI]
|
1.75681e-05
|
|
|
TSD
|
[NCBI]
|
1.56324e-05
|
|
|
TPH1
|
[NCBI]
|
1.48831e-05
|
|
|
ALDOA
|
[NCBI]
|
1.45755e-05
|
|
|
ENO1
|
[NCBI]
|
1.45755e-05
|
|
|
HLF
|
[NCBI]
|
1.45755e-05
|
|
|
SELP
|
[NCBI]
|
1.3042e-05
|
|
|
PLAT
|
[NCBI]
|
1.28264e-05
|
|
|
ADAMTS13
|
[NCBI]
|
1.26198e-05
|
|
|
COL4A5
|
[NCBI]
|
1.16988e-05
|
|
|
amyloidosis vi
|
[NCBI]
|
1.16901e-05
|
|
|
AVPR2
|
[NCBI]
|
1.07825e-05
|
|
|
KAL1
|
[NCBI]
|
1.03822e-05
|
|
|
complement component 2 deficiency
|
[NCBI]
|
1.00129e-05
|
|
|
factor vii deficiency
|
[NCBI]
|
9.67042e-06
|
|
|
PLG
|
[NCBI]
|
9.48928e-06
|
|
|
factor x deficiency
|
[NCBI]
|
9.24951e-06
|
|
|
ALD
|
[NCBI]
|
8.50786e-06
|
|
|
CFB
|
[NCBI]
|
8.33995e-06
|
|
|
XIST
|
[NCBI]
|
7.87095e-06
|
|
|
HGF
|
[NCBI]
|
7.53649e-06
|
|
|
CCR5
|
[NCBI]
|
7.44708e-06
|
|
|
APOE
|
[NCBI]
|
7.16291e-06
|
|
|
AQP2
|
[NCBI]
|
7.12302e-06
|
|
|
F2R
|
[NCBI]
|
6.93977e-06
|
|
|
FGA
|
[NCBI]
|
6.54094e-06
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
6.34528e-06
|
|
|
HRG
|
[NCBI]
|
6.12791e-06
|
|
|
AQP1
|
[NCBI]
|
6.07912e-06
|
|
|
CP
|
[NCBI]
|
5.55277e-06
|
|
|
CAT
|
[NCBI]
|
5.51397e-06
|
|
|
CPB2
|
[NCBI]
|
5.37094e-06
|
|
|
PWS
|
[NCBI]
|
5.07189e-06
|
|
|
FGFR1
|
[NCBI]
|
4.57343e-06
|
|
|
RNASE2
|
[NCBI]
|
4.57343e-06
|
|
|
PCI
|
[NCBI]
|
4.54105e-06
|
|
|
CFTR
|
[NCBI]
|
4.22283e-06
|
|
|
RP
|
[NCBI]
|
4.09857e-06
|
|
|
HFE
|
[NCBI]
|
3.12229e-06
|
|
|
DMD
|
[NCBI]
|
2.98114e-06
|
|
|
CRC
|
[NCBI]
|
2.72489e-06
|
|
|
MBP
|
[NCBI]
|
2.32785e-06
|
|
|
TG
|
[NCBI]
|
1.60821e-06
|
|
|
G6PD
|
[NCBI]
|
1.51211e-06
|
|
|
SLE
|
[NCBI]
|
1.41585e-06
|
|
|
ADA
|
[NCBI]
|
1.32855e-06
|
|
|
AFP
|
[NCBI]
|
6.77143e-07
|
|
|
CEACAM5
|
[NCBI]
|
6.6459e-07
|
|
|
AVP
|
[NCBI]
|
4.32505e-07
|
|
|
TF
|
[NCBI]
|
2.35418e-07
|
|
|
PCNA
|
[NCBI]
|
2.23139e-07
|
|
|
XDH
|
[NCBI]
|
1.17299e-07
|
|
|
CTGF
|
[NCBI]
|
1.10084e-07
|
|
|
MDD
|
[NCBI]
|
7.37016e-08
|
|
|
ALB
|
[NCBI]
|
2.01211e-08
|
|